APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Smoking Products

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Anti-Smoking Products Market Outlook and Growth Opportunities 2026

21 December 2025199 pages

Choose your research edition.

Industry ResearchAnti-Smoking Products Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Smoking Products Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Anti-Smoking Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Smoking Products Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Smoking Products Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Anti-Smoking Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Anti-Smoking Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-Smoking Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Smoking Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Anti-Smoking Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Anti-Smoking Products market include Takeda pharmaceutical, Novartis International, Pfizer, GSK, VMR products, VaporCorp, Revolymer plc, NJOY and McNeil AB, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Anti-Smoking Products market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-Smoking Products and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-Smoking Products revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Anti-Smoking Products market.

Anti-Smoking Products Segment by Company

Takeda pharmaceutical

Novartis International

Pfizer

GSK

VMR products

VaporCorp

Revolymer plc

NJOY

McNeil AB

Lorillard

Imperial Tobacco

Elder Pharma

Cipla

Anti-Smoking Products Segment by Type

Drug therapy

Nicotine Replacement Therapy

E-cigarettes

Anti-Smoking Products Segment by Application

Smokers aged 65 years or older

Smokers aged 45–64

Smokers aged 25–44

Smokers aged 18–24

Anti-Smoking Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Anti-Smoking Products status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Anti-Smoking Products key companies, revenue, market share, and recent developments.

3. To split the Anti-Smoking Products breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Anti-Smoking Products market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Anti-Smoking Products significant trends, drivers, influence factors in global and regions.

6. To analyze Anti-Smoking Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Smoking Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Smoking Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Smoking Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-Smoking Products industry.

Chapter 3: Detailed analysis of Anti-Smoking Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Anti-Smoking Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Anti-Smoking Products in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Anti-Smoking Products Industry Trends Table 2. Anti-Smoking Products Industry Drivers Table 3. Anti-Smoking Products Industry Opportunities and Challenges Table 4. Anti-Smoking Products Industry Restraints Table 5. Global Anti-Smoking Products Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Anti-Smoking Products Revenue Share by Company (2021-2026) Table 7. Global Anti-Smoking Products Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Anti-Smoking Products Key Company Manufacturing Base & Headquarters Table 9. Global Anti-Smoking Products Company, Product Type & Application Table 10. Global Anti-Smoking Products Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Anti-Smoking Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Drug therapy Table 15. Significant Companies of Nicotine Replacement Therapy Table 16. Significant Companies of E-cigarettes Table 17. Global Anti-Smoking Products Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Anti-Smoking Products Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Anti-Smoking Products Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Anti-Smoking Products Sales Value Share by Type (2021-2026) Table 21. Global Anti-Smoking Products Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Smokers aged 65 years or older Table 23. Significant Companies of Smokers aged 45–64 Table 24. Significant Companies of Smokers aged 25–44 Table 25. Significant Companies of Smokers aged 18–24 Table 26. Global Anti-Smoking Products Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Anti-Smoking Products Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Anti-Smoking Products Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Anti-Smoking Products Sales Value Share by Application (2021-2026) Table 30. Global Anti-Smoking Products Sales Value Share by Application (2027-2032) Table 31. Global Anti-Smoking Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Anti-Smoking Products Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Anti-Smoking Products Sales Value Share by Region (2021-2026) Table 34. Global Anti-Smoking Products Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Anti-Smoking Products Sales Value Share by Region (2027-2032) Table 36. Global Anti-Smoking Products Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Anti-Smoking Products Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Anti-Smoking Products Sales Value Market Share by Country (2021-2026) Table 39. Global Anti-Smoking Products Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Anti-Smoking Products Sales Value Market Share by Country (2027-2032) Table 41. Takeda pharmaceutical Company Information Table 42. Takeda pharmaceutical Business Overview Table 43. Takeda pharmaceutical Anti-Smoking Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Takeda pharmaceutical Anti-Smoking Products Product Portfolio Table 45. Takeda pharmaceutical Recent Development Table 46. Novartis International Company Information Table 47. Novartis International Business Overview Table 48. Novartis International Anti-Smoking Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Novartis International Anti-Smoking Products Product Portfolio Table 50. Novartis International Recent Development Table 51. Pfizer Company Information Table 52. Pfizer Business Overview Table 53. Pfizer Anti-Smoking Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Pfizer Anti-Smoking Products Product Portfolio Table 55. Pfizer Recent Development Table 56. GSK Company Information Table 57. GSK Business Overview Table 58. GSK Anti-Smoking Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. GSK Anti-Smoking Products Product Portfolio Table 60. GSK Recent Development Table 61. VMR products Company Information Table 62. VMR products Business Overview Table 63. VMR products Anti-Smoking Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. VMR products Anti-Smoking Products Product Portfolio Table 65. VMR products Recent Development Table 66. VaporCorp Company Information Table 67. VaporCorp Business Overview Table 68. VaporCorp Anti-Smoking Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. VaporCorp Anti-Smoking Products Product Portfolio Table 70. VaporCorp Recent Development Table 71. Revolymer plc Company Information Table 72. Revolymer plc Business Overview Table 73. Revolymer plc Anti-Smoking Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Revolymer plc Anti-Smoking Products Product Portfolio Table 75. Revolymer plc Recent Development Table 76. NJOY Company Information Table 77. NJOY Business Overview Table 78. NJOY Anti-Smoking Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. NJOY Anti-Smoking Products Product Portfolio Table 80. NJOY Recent Development Table 81. McNeil AB Company Information Table 82. McNeil AB Business Overview Table 83. McNeil AB Anti-Smoking Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. McNeil AB Anti-Smoking Products Product Portfolio Table 85. McNeil AB Recent Development Table 86. Lorillard Company Information Table 87. Lorillard Business Overview Table 88. Lorillard Anti-Smoking Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Lorillard Anti-Smoking Products Product Portfolio Table 90. Lorillard Recent Development Table 91. Imperial Tobacco Company Information Table 92. Imperial Tobacco Business Overview Table 93. Imperial Tobacco Anti-Smoking Products Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Imperial Tobacco Anti-Smoking Products Product Portfolio Table 95. Imperial Tobacco Recent Development Table 96. Elder Pharma Company Information Table 97. Elder Pharma Business Overview Table 98. Elder Pharma Anti-Smoking Products Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Elder Pharma Anti-Smoking Products Product Portfolio Table 100. Elder Pharma Recent Development Table 101. Cipla Company Information Table 102. Cipla Business Overview Table 103. Cipla Anti-Smoking Products Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Cipla Anti-Smoking Products Product Portfolio Table 105. Cipla Recent Development Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. Anti-Smoking Products Product Image Figure 2. Global Anti-Smoking Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Smoking Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-Smoking Products Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Drug therapy Image Figure 8. Nicotine Replacement Therapy Image Figure 9. E-cigarettes Image Figure 10. Global Anti-Smoking Products Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Anti-Smoking Products Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Anti-Smoking Products Sales Value Share by Type (2021-2032) Figure 13. Smokers aged 65 years or older Image Figure 14. Smokers aged 45–64 Image Figure 15. Smokers aged 25–44 Image Figure 16. Smokers aged 18–24 Image Figure 17. Global Anti-Smoking Products Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Anti-Smoking Products Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Anti-Smoking Products Sales Value Share by Application (2021-2032) Figure 20. Global Anti-Smoking Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Anti-Smoking Products Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Anti-Smoking Products Sales Value (2021-2032) & (US$ Million) Figure 23. North America Anti-Smoking Products Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Anti-Smoking Products Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Anti-Smoking Products Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Anti-Smoking Products Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Anti-Smoking Products Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Anti-Smoking Products Sales Value (2021-2032) & (US$ Million) Figure 29. South America Anti-Smoking Products Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Anti-Smoking Products Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Anti-Smoking Products Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Anti-Smoking Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Drug therapy
  • Nicotine Replacement Therapy
  • E-cigarettes
Applications
  • Smokers aged 65 years or older
  • Smokers aged 45–64
  • Smokers aged 25–44
  • Smokers aged 18–24
Companies covered
  • Takeda pharmaceutical
  • Novartis International
  • Pfizer
  • GSK
  • VMR products
  • VaporCorp
  • Revolymer plc
  • NJOY
  • McNeil AB
  • Lorillard
  • Imperial Tobacco
  • Elder Pharma
  • Cipla

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anti-Smoking Products Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anti-Smoking Products Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Anti-Smoking Products Market Dynamics
  1. 2.1 Anti-Smoking Products Industry Trends
  2. 2.2 Anti-Smoking Products Industry Drivers
  3. 2.3 Anti-Smoking Products Industry Opportunities and Challenges
  4. 2.4 Anti-Smoking Products Industry Restraints
3 Anti-Smoking Products Market by Company
  1. 3.1 Global Anti-Smoking Products Company Revenue Ranking in 2025
  2. 3.2 Global Anti-Smoking Products Revenue by Company (2021-2026)
  3. 3.3 Global Anti-Smoking Products Company Ranking (2024-2026)
  4. 3.4 Global Anti-Smoking Products Company Manufacturing Base and Headquarters
  5. 3.5 Global Anti-Smoking Products Company Product Type and Application
  6. 3.6 Global Anti-Smoking Products Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Anti-Smoking Products Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Anti-Smoking Products Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Anti-Smoking Products Market by Type
  1. 4.1 Anti-Smoking Products Type Introduction
  2. 4.1.1 Drug therapy
  3. 4.1.2 Nicotine Replacement Therapy
  4. 4.1.3 E-cigarettes
  5. 4.2 Global Anti-Smoking Products Sales Value by Type
  6. 4.2.1 Global Anti-Smoking Products Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Anti-Smoking Products Sales Value by Type (2021-2032)
  8. 4.2.3 Global Anti-Smoking Products Sales Value Share by Type (2021-2032)
5 Anti-Smoking Products Market by Application
  1. 5.1 Anti-Smoking Products Application Introduction
  2. 5.1.1 Smokers aged 65 years or older
  3. 5.1.2 Smokers aged 45–64
  4. 5.1.3 Smokers aged 25–44
  5. 5.1.4 Smokers aged 18–24
  6. 5.2 Global Anti-Smoking Products Sales Value by Application
  7. 5.2.1 Global Anti-Smoking Products Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Anti-Smoking Products Sales Value by Application (2021-2032)
  9. 5.2.3 Global Anti-Smoking Products Sales Value Share by Application (2021-2032)
6 Anti-Smoking Products Regional Value Analysis
  1. 6.1 Global Anti-Smoking Products Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-Smoking Products Sales Value by Region (2021-2032)
  3. 6.2.1 Global Anti-Smoking Products Sales Value by Region: 2021-2026
  4. 6.2.2 Global Anti-Smoking Products Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anti-Smoking Products Sales Value (2021-2032)
  7. 6.3.2 North America Anti-Smoking Products Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Anti-Smoking Products Sales Value (2021-2032)
  10. 6.4.2 Europe Anti-Smoking Products Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Anti-Smoking Products Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Anti-Smoking Products Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Anti-Smoking Products Sales Value (2021-2032)
  16. 6.6.2 South America Anti-Smoking Products Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Anti-Smoking Products Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Anti-Smoking Products Sales Value Share by Country, 2025 VS 2032
7 Anti-Smoking Products Country-level Value Analysis
  1. 7.1 Global Anti-Smoking Products Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Anti-Smoking Products Sales Value by Country (2021-2032)
  3. 7.2.1 Global Anti-Smoking Products Sales Value by Country (2021-2026)
  4. 7.2.2 Global Anti-Smoking Products Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Anti-Smoking Products Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Anti-Smoking Products Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Anti-Smoking Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda pharmaceutical
  2. 8.1.1 Takeda pharmaceutical Company Information
  3. 8.1.2 Takeda pharmaceutical Business Overview
  4. 8.1.3 Takeda pharmaceutical Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda pharmaceutical Anti-Smoking Products Product Portfolio
  6. 8.1.5 Takeda pharmaceutical Recent Developments
  7. 8.2 Novartis International
  8. 8.2.1 Novartis International Company Information
  9. 8.2.2 Novartis International Business Overview
  10. 8.2.3 Novartis International Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis International Anti-Smoking Products Product Portfolio
  12. 8.2.5 Novartis International Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Anti-Smoking Products Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 GSK
  20. 8.4.1 GSK Company Information
  21. 8.4.2 GSK Business Overview
  22. 8.4.3 GSK Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GSK Anti-Smoking Products Product Portfolio
  24. 8.4.5 GSK Recent Developments
  25. 8.5 VMR products
  26. 8.5.1 VMR products Company Information
  27. 8.5.2 VMR products Business Overview
  28. 8.5.3 VMR products Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  29. 8.5.4 VMR products Anti-Smoking Products Product Portfolio
  30. 8.5.5 VMR products Recent Developments
  31. 8.6 VaporCorp
  32. 8.6.1 VaporCorp Company Information
  33. 8.6.2 VaporCorp Business Overview
  34. 8.6.3 VaporCorp Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  35. 8.6.4 VaporCorp Anti-Smoking Products Product Portfolio
  36. 8.6.5 VaporCorp Recent Developments
  37. 8.7 Revolymer plc
  38. 8.7.1 Revolymer plc Company Information
  39. 8.7.2 Revolymer plc Business Overview
  40. 8.7.3 Revolymer plc Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Revolymer plc Anti-Smoking Products Product Portfolio
  42. 8.7.5 Revolymer plc Recent Developments
  43. 8.8 NJOY
  44. 8.8.1 NJOY Company Information
  45. 8.8.2 NJOY Business Overview
  46. 8.8.3 NJOY Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  47. 8.8.4 NJOY Anti-Smoking Products Product Portfolio
  48. 8.8.5 NJOY Recent Developments
  49. 8.9 McNeil AB
  50. 8.9.1 McNeil AB Company Information
  51. 8.9.2 McNeil AB Business Overview
  52. 8.9.3 McNeil AB Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  53. 8.9.4 McNeil AB Anti-Smoking Products Product Portfolio
  54. 8.9.5 McNeil AB Recent Developments
  55. 8.10 Lorillard
  56. 8.10.1 Lorillard Company Information
  57. 8.10.2 Lorillard Business Overview
  58. 8.10.3 Lorillard Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lorillard Anti-Smoking Products Product Portfolio
  60. 8.10.5 Lorillard Recent Developments
  61. 8.11 Imperial Tobacco
  62. 8.11.1 Imperial Tobacco Company Information
  63. 8.11.2 Imperial Tobacco Business Overview
  64. 8.11.3 Imperial Tobacco Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Imperial Tobacco Anti-Smoking Products Product Portfolio
  66. 8.11.5 Imperial Tobacco Recent Developments
  67. 8.12 Elder Pharma
  68. 8.12.1 Elder Pharma Company Information
  69. 8.12.2 Elder Pharma Business Overview
  70. 8.12.3 Elder Pharma Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Elder Pharma Anti-Smoking Products Product Portfolio
  72. 8.12.5 Elder Pharma Recent Developments
  73. 8.13 Cipla
  74. 8.13.1 Cipla Company Information
  75. 8.13.2 Cipla Business Overview
  76. 8.13.3 Cipla Anti-Smoking Products Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cipla Anti-Smoking Products Product Portfolio
  78. 8.13.5 Cipla Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst